HC Wainwright & Co. Downgrades Cardiff Oncology to Neutral

Benzinga Newsdesk www.benzinga.com Negative 89.3%

Neg 89.3% Neu 0% Pos 0%

HC Wainwright & Co. analyst Robert Burns downgrades Cardiff Oncology (NASDAQ:CRDF) from Buy to Neutral.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Downgrades Cardiff Oncology to Neutral